<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01387477</url>
  </required_header>
  <id_info>
    <org_study_id>IAAM 2011-01</org_study_id>
    <nct_id>NCT01387477</nct_id>
  </id_info>
  <brief_title>Lactate to Treat Hypoglycemia</brief_title>
  <official_title>Comparison of Two Strategies of Hypoglycemia Correction in ICU</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institut d'Anesthesiologie des Alpes Maritimes</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Institut d'Anesthesiologie des Alpes Maritimes</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Tight glucose control in intensive care has become a major concern, allowing a reduction in&#xD;
      morbidity and mortality. However, its use is limited by the percentage of hypoglycemia which&#xD;
      can have severe consequences on the brain. The bispectral index (BIS) is derived from the EEG&#xD;
      and measures of brain electrical activity noninvasively. It has already been shown that its&#xD;
      value changes according to hypoglycemia and its correction. Furthermore, if the hormonal&#xD;
      response to hypoglycemia is well known in healthy and diabetic subjects, it is not the case&#xD;
      in ICU patient. The usual treatment of hypoglycemia is based on parenteral infusion of&#xD;
      glucose. Btu this can lead to a hyperglycemic rebound that can be deleterious. Lactate is a&#xD;
      substrate for gluconeogenesis and an energy substrate during critical situations. It has been&#xD;
      shown to improve neurological tests during hypoglycaemia and had cerebral protective&#xD;
      properties after a severe head injury. The hypothesis of this study is that sodium lactate is&#xD;
      superior than the 30% glucose to correct hypoglycemia in the ICU in terms of glycemic&#xD;
      variation, brain function and hormonal response.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Withdrawn</overall_status>
  <start_date type="Anticipated">June 2011</start_date>
  <completion_date type="Anticipated">June 2012</completion_date>
  <primary_completion_date type="Anticipated">June 2012</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Area under the curve of the glycemia</measure>
    <time_frame>30 minutes</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Bispectral index variation</measure>
    <time_frame>60 minutes</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maximum change in glycemia</measure>
    <time_frame>30 minutes</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in growth hormone and cortisol</measure>
    <time_frame>180 minutes</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Need for glucose infusion for persistent hypoglycemia</measure>
    <time_frame>30 minutes</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Hypoglycemia</condition>
  <arm_group>
    <arm_group_label>Lactate</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>infusion of 66 mmol of lactate</description>
  </arm_group>
  <arm_group>
    <arm_group_label>glucose</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>infusion of 33 mmol of glucose</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lactate</intervention_name>
    <description>Infusion of 66 mmol of lactate</description>
    <arm_group_label>Lactate</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Glucose</intervention_name>
    <description>Infusion of 33 mmol of glucose</description>
    <arm_group_label>glucose</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  hypoglycemia under 0.6 g/L&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  hepatic failure&#xD;
&#xD;
          -  hyperlactatemia above 5 mmol/L&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jean-Christophe Orban, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Nice University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Réanimation médico-chirurgicale</name>
      <address>
        <city>Nice</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>June 30, 2011</study_first_submitted>
  <study_first_submitted_qc>July 1, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 4, 2011</study_first_posted>
  <last_update_submitted>July 29, 2020</last_update_submitted>
  <last_update_submitted_qc>July 29, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 31, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Institut d'Anesthesiologie des Alpes Maritimes</investigator_affiliation>
    <investigator_full_name>Professor C ICHAI</investigator_full_name>
    <investigator_title>Professor Chair of IAAM</investigator_title>
  </responsible_party>
  <keyword>hypoglycemia</keyword>
  <keyword>lactate</keyword>
  <keyword>glucose</keyword>
  <keyword>ICU</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypoglycemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

